Related references
Note: Only part of the references are listed.State of the Science: The role of HIPEC in the treatment of ovarian cancer
Thanh H. Dellinger et al.
GYNECOLOGIC ONCOLOGY (2021)
A randomized phase II trial of secondary cytoreductive surgery (SCS) +/- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC).
Oliver Zivanovic et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
HIPEC in advanced epithelial ovarian cancer: why is there controversy?
Jan B. Vermorken et al.
CURRENT OPINION IN ONCOLOGY (2020)
Intraperitoneal chemotherapy: Hot, timely, and relevant?
Helen J. Mackay et al.
CANCER (2020)
Systemic inflammatory response after hyperthermic intraperitoneal chemotherapy (HIPEC): The perfusion protocol matters!
Lilian Roth et al.
EJSO (2019)
Saved by the evidence: Hyperthermic intraperitoneal chemotherapy still has a role to play in ovarian cancer
Vincent Lavoue et al.
EJSO (2019)
Is There a Role for Intraperitoneal Chemotherapy, Including HIPEC, in the Management of Ovarian Cancer?
Ignace Vergote et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Hyperthermic intraperitoneal chemotherapy does not improve survival in advanced ovarian cancer
Ignace Vergote et al.
CANCER (2019)
HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?
C. Fotopoulou et al.
ANNALS OF ONCOLOGY (2018)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W. J. van Driel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer
R. Wendel Naumann et al.
GYNECOLOGIC ONCOLOGY (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop
Bhushan Thakur et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90
B. Zunino et al.
ONCOGENE (2016)
Effects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies
Theodora Mantso et al.
SEMINARS IN CANCER BIOLOGY (2016)
Hyperthermia: an effective strategy to induce apoptosis in cancer cells
Kanwal Ahmed et al.
APOPTOSIS (2015)
Hyperthermia, Radiation and Chemotherapy: The Role of Heat in Multidisciplinary Cancer Care
Mark Hurwitz et al.
SEMINARS IN ONCOLOGY (2014)
BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study
J. L. Lesnock et al.
BRITISH JOURNAL OF CANCER (2013)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Heat Shock Protein 70, Released from Heat-Stressed Tumor Cells, Initiates Antitumor Immunity by Inducing Tumor Cell Chemokine Production and Activating Dendritic Cells via TLR4 Pathway
Taoyong Chen et al.
JOURNAL OF IMMUNOLOGY (2009)
Heat shock proteins in cancer: chaperones of tumorigenesis
SK Calderwood et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Java Treeview-extensible visualization of microarray data
AJ Saldanha
BIOINFORMATICS (2004)
Open source clustering software
MJL de Hoon et al.
BIOINFORMATICS (2004)